Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Gildeuretinol acetate by Alkeus Pharmaceuticals for Geographic Atrophy: Likelihood of Approval
Gildeuretinol acetate is under clinical development by Alkeus Pharmaceuticals and currently in Phase III for Geographic Atrophy. According to GlobalData,...
Data Insights
Gildeuretinol acetate by Alkeus Pharmaceuticals for Juvenile Macular Degeneration (Stargardt Disease): Likelihood of Approval
Gildeuretinol acetate is under clinical development by Alkeus Pharmaceuticals and currently in Phase II for Juvenile Macular Degeneration (Stargardt Disease)....